CONMED Corp. (CNMD)
51.50
-1.33
(-2.52%)
USD |
NYSE |
Nov 06, 16:00
51.45
-0.05
(-0.10%)
After-Hours: 20:00
CONMED Net Income (Quarterly) : 19.80M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 19.80M |
| June 30, 2026 | 23.07M |
| March 31, 2026 | 13.83M |
| December 31, 2025 | 16.74M |
| September 30, 2025 | 2.859M |
| June 30, 2025 | 21.42M |
| March 31, 2025 | 6.036M |
| December 31, 2024 | 33.75M |
| September 30, 2024 | 48.98M |
| June 30, 2024 | 29.98M |
| March 31, 2024 | 19.71M |
| December 31, 2023 | 33.07M |
| September 30, 2023 | 15.84M |
| June 30, 2023 | 13.73M |
| March 31, 2023 | 1.819M |
| December 31, 2022 | 26.58M |
| September 30, 2022 | 46.15M |
| June 30, 2022 | -168.29M |
| March 31, 2022 | 14.98M |
| December 31, 2021 | 24.44M |
| September 30, 2021 | 14.95M |
| June 30, 2021 | 13.29M |
| March 31, 2021 | 9.86M |
| December 31, 2020 | 24.14M |
| September 30, 2020 | 6.85M |
| Date | Value |
|---|---|
| June 30, 2020 | -27.40M |
| March 31, 2020 | 5.927M |
| December 31, 2019 | 14.93M |
| September 30, 2019 | 6.97M |
| June 30, 2019 | 5.695M |
| March 31, 2019 | 1.021M |
| December 31, 2018 | 15.65M |
| September 30, 2018 | 5.825M |
| June 30, 2018 | 8.719M |
| March 31, 2018 | 10.66M |
| December 31, 2017 | 46.70M |
| September 30, 2017 | 7.197M |
| June 30, 2017 | 6.139M |
| March 31, 2017 | -4.545M |
| December 31, 2016 | 6.708M |
| September 30, 2016 | 7.337M |
| June 30, 2016 | 2.884M |
| March 31, 2016 | -2.265M |
| December 31, 2015 | 7.852M |
| September 30, 2015 | 8.873M |
| June 30, 2015 | 7.461M |
| March 31, 2015 | 6.312M |
| December 31, 2014 | 11.34M |
| September 30, 2014 | 1.972M |
| June 30, 2014 | 10.26M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 141.17M |
| Becton, Dickinson & Co. | 696.00M |
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -5.471M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 335.59M |
| Total Expenses (Quarterly) | 315.79M |
| EPS Diluted (Quarterly) | 0.6571 |
| Enterprise Value | 2.306B |
| Gross Profit Margin (Quarterly) | 10.53% |
| Profit Margin (Quarterly) | 5.90% |
| Earnings Yield | 4.69% |
| Operating Earnings Yield | 1.39% |
| Normalized Earnings Yield | 6.018 |